Effect of Nitrous Oxide on Depressive Patients and Volunteers

  • M. A. Gillman
  • N. Matussek
  • F. J. Lichtigfeld


Nitrous Oxide (N2O) at analgesic concentrations has been shown to cause naloxone reversible analgesia both experimentally1,2 and clinically3,4.


Nitrous Oxide LUTEINIZING Hormone Alcohol Withdrawal Growth Hormone Response Luteinizing Hormone Release Hormone 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Berkowitz, B. A., Ngai, S. H., and Finck, A. D., 1976, Nitrous oxide analgesia: Resemblance to opiate action, Science, 194: 967PubMedCrossRefGoogle Scholar
  2. 2.
    Berkowitz, B. A., Finck, A. D., and Ngai, S. H., Nitrous oxide analgesia: Reversal by nalaxone and development of tolerance J. Pharmacol Exp. Ther, 203:539Google Scholar
  3. 3.
    Gillman, M. A., Kok, L., and Lichtigfeld, F. J., 1980, Paradoxical effect of naloxone on nitrous oxide analgesia in man, Eur. J. Pharmacol, 61:175Google Scholar
  4. 4.
    Gillman, M. A., and Lichtigfeld, F. J., 1981. A comparison of the effects of morphine sulphate and nitrous oxide on chronic pain states in man, J. Neurol. Sci, 49:41PubMedCrossRefGoogle Scholar
  5. 5.
    Ahmed, S. M., and Byrne, W. L. Opiate receptor binding studies influence of a reversible sulfhydryl reagent, in “Endogenous and exogenous opiate agonists and antagonists”, E. L. Way ed., Pergamon, New York (1980)Google Scholar
  6. 6.
    Daras, C., Cantrill, R. C., and Gillman, M. A., 1983 (3H) naloxone displacement: evidence for nitrous oxide as opioid receptor agonist, Eur. J. Pharmacol, 89:177.PubMedCrossRefGoogle Scholar
  7. 7.
    Bunney, W. E., 1978, Drug therapy and psychobiological research advances in psychoses in the past decade, Am. J. Psychiat. 135:8PubMedGoogle Scholar
  8. 8.
    Vereby, K., Volavka, J., and Clonet, D., 1978, Endorphins in psychiatry, Arch. Gen. Psychiatry, 35:877.CrossRefGoogle Scholar
  9. 9.
    Lichtigfeld, F. J., and Gillman, M. A., 1982. Treatment of alcoholic withdrawal state with oxygen and nitrous oxide S. A. Med. J. 61:349Google Scholar
  10. 10.
    Gillman, M. A., and Lichtigfeld, F. J. A receptor hypothesis of the alcohol withdrawal state in CNS receptors — From molecular pharmacology to behaviour P Mandel and F. V. de Feudis eds., Raven Press, New York (in press)Google Scholar
  11. 11.
    Björkqvist, S. E., 1975, Clonidine in alcohol withdrawal, Acta Psychiat. Scand. 52:256PubMedCrossRefGoogle Scholar
  12. 12.
    Pettibone, D. J., and Mueller, G. P., 1981. Clonidine release inimunoreactive beta-endorphin from rats pars distalis Brain Res. 221:409PubMedCrossRefGoogle Scholar
  13. 13.
    Matussek, N., Ackenheil, M., Hippins, H., Muller, F., Schröder, Schultes, H., and Hasilewski, B., 1980. Effect of clonidine on growth hormone release in psychiatric patients and controls, Psychiat Res. 2:25CrossRefGoogle Scholar
  14. 14.
    Lindberg, T., Larsen, V., Kehlet, H., and Jacobsen, E., 1981 Respiratory, analgesic and endorcrine responses to an enkephalin analogue in normal man. Acta. Anaesth. Scand. 25:254CrossRefGoogle Scholar
  15. 15.
    Morley, H. E., 1981 The endocrinology of the opiates and opioid peptides Metabolism 30:195PubMedCrossRefGoogle Scholar
  16. 16.
    Report, J., F., Quigley, M. E., and Yen, S. S. C., 1981 Endogenous opiates modulate pulsatile luteinizing release in humans, J. Clin. Endocrin Metab. 52:583CrossRefGoogle Scholar
  17. 17.
    Luria, R. E. 1975. The validity and rehability of the visual analogue mood state. J. Psychiat Res. 12:51PubMedCrossRefGoogle Scholar
  18. 18.
    Davis, K. L., Berger, P. A., Hollister, L. E., and Defraetes, E., 1978. Physostigmine for mania Arch Gen. Psychiat. 35:119Google Scholar
  19. 19.
    Dekeyser, Y. F. L., 1980. Hypothalamic releasing factor primary and situational depression, Int. J. Neurol. 14:219Google Scholar
  20. 20.
    Brill, N. Q., Crumpton, E., Eituson, S., Grayson, H. M., Hellman, L. I., and Richards, R. A., 1959. Arch.Neurol. Psychiat. 81:627CrossRefGoogle Scholar
  21. 21.
    Matussek, N. Effect of amphetamine and clonidine on growth hormone release in psychiatric patients and controls, in Depressive Disorders (symposie Medica Hoechst 13) S. Gavattini e.d. F. K. Schattauer Verlag. Stuttgart. (1978)Google Scholar
  22. 22.
    Gillman, M. A., and Lichtigfeld, F. J., 1983. Therapeutic use of N2O in Psychiatry. Free paper VII World Congress of PschiatryGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1985

Authors and Affiliations

  • M. A. Gillman
    • 1
    • 4
  • N. Matussek
    • 2
  • F. J. Lichtigfeld
    • 3
    • 4
  1. 1.Univ. Wits. Med. SchoolJohannesburgSouth Africa
  2. 2.Psychiatry Hospital, Univ.MunichGermany
  3. 3.PsychiatristPort ShepstoneSouth Africa
  4. 4.S.A. Brain Res. Inst.JohannesburgSouth Africa

Personalised recommendations